5HZ-12019-26115
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 037 / NH
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-09
Health check-in — day 0, dose 1Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-16
- 2021-05-02
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
- 2021-10-08
-
2021-10-26
Dose 2 — Pfizer-BioNTech
-
2021-11-11
Survey response — day 14, dose 2MedDRA: Throat irritation — Feeling: GoodFree text: Scratchy throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Survey response — day 21, dose 2MedDRA: Cough, Nasopharyngitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: A cold and a nasty coughMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-18
Call successfulParticipant prefers to complete VAERS report online
- 2021-11-23
- 2021-11-30
- 2021-12-07
-
2022-01-25
Survey response — 3 months, dose 2MedDRA: Diarrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-25
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-01-26
- 2022-04-28
-
2022-10-28
Survey response — 12 months, dose 2MedDRA: Cough, Rhinorrhoea, Throat irritation — Feeling: FairFree text: Runny nose, scratchy throat, occasional coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-16 | Successful 2021-11-18 |
Participant prefers to complete VAERS report online |
| 2022-01-25 | Unsuccessful |
Free text
Release 10 — day 14, dose 2
Symptoms: Scratchy throat
Release 10 — day 21, dose 2
Symptoms: A cold and a nasty cough
Release 11 — 3 months, dose 2
Symptoms: Diarrhea
Release 12 — 12 months, dose 2
Symptoms: Runny nose, scratchy throat, occasional cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release